A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression
Convalife (Shanghai) Co., Ltd.
Convalife (Shanghai) Co., Ltd.
University of California, Irvine
Daiichi Sankyo
Mayo Clinic
Tempus AI
University of California, Irvine
Elevation Oncology
EpicentRx, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Memorial Sloan Kettering Cancer Center
pharmaand GmbH
Northwestern University
Roswell Park Cancer Institute
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
University of California, San Francisco
Hoag Memorial Hospital Presbyterian
Scripps Health